Additional presence of dendritic cells, macrophages, and other antigen presenting cells in the in-vivo tumor lesion milieu should give additional type I interferon activity which leads to activation of NK cells and CD8 Tcells (66). The gene discussed is CD8A; the disease is neoplasm.